The first presentation of COVID-19 two hours after vaccination in a patient with multiple sclerosis: Can COVID vaccine provoke cytokine storm in a patient with asymptomatic COVID-19?

Authors

  • Fereshteh Ghadiri Multiple Sclerosis Research Center, Neuroscience institute, Tehran University of Medical Sciences, Tehran, Iran
  • Mohammad Ali Sahraian Multiple Sclerosis Research Center, Neuroscience institute, Tehran University of Medical Sciences, Tehran, Iran
  • Abdorreza Naser Moghadasi Multiple Sclerosis Research Center, Neuroscience institute, Tehran University of Medical Sciences, Tehran, Iran

DOI:

https://doi.org/10.18502/cjn.v20i4.8353

Keywords:

COVID-19; Vaccination; Multiple Sclerosis; Virology; Rituximab

Abstract

The article's abstract is not available.

Downloads

Published

2022-01-12

Issue

Volume (20) issue (4)

Section

Articles